Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|September 5, 2009
Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Pharmacoepidemiology and Drug Safety|November 29, 2022
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancersLaurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
Clinics and Research in Hepatology and Gastroenterology|June 17, 2021
Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasionLorraine Blaise, Helena Pereira, Valérie Vilgrain, et al.
Hepatology (Baltimore, Md.)|April 20, 2026
Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortiumFasiha Kanwal, Ziding Feng, Yujin Hoshida, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosisPierre Nahon, Marie Najean, Richard Layese, et al.
Molecular Cancer Research : MCR|January 30, 2007
Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasionAngela Sutton, Veronique Friand, Severine Brulé-Donneger, et al.
Clinics and Research in Hepatology and Gastroenterology|December 17, 2019
Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosisJean-Pierre Zarski, Sandra David-Tchouda, Candice Trocme, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up of primary malignant liver tumoursPierre Nahon, Christophe Aubé, Lucile Moga, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 22, 2018
Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosisManon Allaire, Samia Rekik, Richard Layese, et al.
Journal of Medical Microbiology|March 6, 2025
Comprehensive toolkit integrating lifestyle and clinical questionnaires with gut microbiota profiling via rectal swabs: application in intensive care cirrhotic patientsJulie Marin, Mohamed Ghalayini, Younes Kaoudji, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|September 5, 2009
Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Pharmacoepidemiology and Drug Safety|November 29, 2022
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancersLaurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
Clinics and Research in Hepatology and Gastroenterology|June 17, 2021
Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasionLorraine Blaise, Helena Pereira, Valérie Vilgrain, et al.
Hepatology (Baltimore, Md.)|April 20, 2026
Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortiumFasiha Kanwal, Ziding Feng, Yujin Hoshida, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosisPierre Nahon, Marie Najean, Richard Layese, et al.
Molecular Cancer Research : MCR|January 30, 2007
Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasionAngela Sutton, Veronique Friand, Severine Brulé-Donneger, et al.
Clinics and Research in Hepatology and Gastroenterology|December 17, 2019
Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosisJean-Pierre Zarski, Sandra David-Tchouda, Candice Trocme, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up of primary malignant liver tumoursPierre Nahon, Christophe Aubé, Lucile Moga, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 22, 2018
Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosisManon Allaire, Samia Rekik, Richard Layese, et al.
Journal of Medical Microbiology|March 6, 2025
Comprehensive toolkit integrating lifestyle and clinical questionnaires with gut microbiota profiling via rectal swabs: application in intensive care cirrhotic patientsJulie Marin, Mohamed Ghalayini, Younes Kaoudji, et al.
Pageof 21